KRAS mutations are the most frequently acquired genetic alteration in PDAC, and detecting this mutation from pancreatic tissue has been helpful in the diagnosis of pancreatic cancer [5, 10]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.